USA - NASDAQ:HTGM - US40434H3021 - Common Stock
We assign a fundamental rating of 1 out of 10 to HTGM. HTGM was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of HTGM have multiple concerns. HTGM is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | N/A | ||
ROE | N/A | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 21.69% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 7.1 | ||
Debt/FCF | N/A | ||
Altman-Z | -35.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.4 | ||
Quick Ratio | 1.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.48
-0.12 (-20%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.17 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.24 | ||
P/tB | 2.24 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | N/A | ||
ROE | N/A | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 21.69% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 7.1 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 4.28% | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.4 | ||
Quick Ratio | 1.3 | ||
Altman-Z | -35.3 |